Matinas BioPharma Reports Third Quarter 2021 Financial Results and Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/27/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. DRI
8. RKLB
9. SPCX
10. NKE

Go back to Matinas BioPharma Reports Third Quarter 2021 Financial Results and Operational Highlights

Matinas BioPharma (MTNB) Misses Q3 EPS by 1c; Reports Cash and Cash Equivalents of $53.8M

November 8, 2021 6:36 AM EST

Matinas BioPharma (NYSE: MTNB) reported Q3 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02).

For earnings history and earnings-related data on Matinas BioPharma (MTNB) click here.

... More